PharmChem, Inc.
PCHM
$3.40
$0.0270.80%
OTC PK
| 09/30/2003 | 06/30/2003 | 03/31/2003 | 12/31/2002 | 09/30/2002 | |
|---|---|---|---|---|---|
| Revenue | 27.62M | 27.99M | 28.94M | 30.09M | 30.94M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 27.62M | 27.99M | 28.94M | 30.09M | 30.94M |
| Cost of Revenue | 21.25M | 21.77M | 22.47M | 23.01M | 28.48M |
| Gross Profit | 6.36M | 6.23M | 6.47M | 7.07M | 2.46M |
| SG&A Expenses | 7.48M | 7.69M | 7.64M | 7.86M | 9.97M |
| Depreciation & Amortization | -- | -- | -- | -- | 33.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.74M | 29.46M | 30.11M | 30.87M | 38.48M |
| Operating Income | -1.12M | -1.47M | -1.17M | -783.00K | -7.54M |
| Income Before Tax | -990.00K | -2.06M | -1.70M | -1.36M | -2.28M |
| Income Tax Expenses | 0.00 | 0.00 | 13.00K | -69.00K | -115.00K |
| Earnings from Continuing Operations | -0.99 | -2.06 | -1.72 | -1.29 | -2.17 |
| Earnings from Discontinued Operations | 0.00 | 0.00 | 0.00 | 4.64M | 4.91M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -990.00K | -2.06M | -1.72M | 3.34M | 2.75M |
| EBIT | -1.12M | -1.47M | -1.17M | -783.00K | -7.54M |
| EBITDA | 1.01M | 756.00K | 1.11M | 1.47M | -5.31M |
| EPS Basic | -0.17 | -0.35 | -0.29 | 0.57 | 0.47 |
| Normalized Basic EPS | -0.18 | -0.22 | -0.18 | -0.15 | -0.87 |
| EPS Diluted | -0.18 | -0.36 | -0.30 | 0.57 | 0.46 |
| Normalized Diluted EPS | -0.18 | -0.22 | -0.18 | -0.15 | -0.87 |
| Average Basic Shares Outstanding | 23.41M | 23.41M | 23.41M | 23.41M | 23.41M |
| Average Diluted Shares Outstanding | 23.48M | 23.41M | 23.41M | 23.41M | 23.41M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |